REQUEST A DEMO
Total
USD $0.00
Search more companies

Neimeth International Pharmaceuticals Plc (Nigeria)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Neimeth International Pharmaceuticals Plc Profile Updated: August 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Neimeth International Pharmaceuticals Plc. is the resultant Company from the Mazi Sam I. Ohuabunwa led Management-Buy-Out of the 60% equity holding of Pfizer Inc. New York, USA in Pfizer Products Plc. This Management-Buy-Out took place in May 1997 when Pfizer Inc. in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc.,the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.

Headquarters
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun
Lagos; Lagos;

Contact Details: Purchase the Neimeth International Pharmaceuticals Plc report to view the information.

Website: http://www.neimethplc.com.ng

Basic Information
Total Employees:
Purchase the Neimeth International Pharmaceuticals Plc report to view the information.
Outstanding Shares:
Purchase the Neimeth International Pharmaceuticals Plc report to view the information.
Registered Capital:
Purchase the Neimeth International Pharmaceuticals Plc report to view the information.
Financial Auditors:
Purchase the Neimeth International Pharmaceuticals Plc report to view the information.
Incorporation Date:
1957
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
19.19%
Purchase this report to view the information.
10.55%
Purchase this report to view the information.
6.08%
Purchase this report to view the information.
3.33%
Company Performance
Financial values in the chart are available after Neimeth International Pharmaceuticals Plc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency NGN. Absolute financial data is included in the purchased report.
Net sales revenue
73.04%
Total operating revenue
69.04%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
1.45%
Total equity
-57.15%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
164.97%
Quick Ratio
-0.92%
Cash Ratio
-0.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?